. . . . . . . . . "\"ELLENCE is contraindicated in patients with: Severe myocardial insufficiency [see Warnings and Precautions (5.1) Recent myocardial infarction or severe arrhythmias, or previous treatment with maximum cumulative dose of anthracyclines [see Warnings and Precautions (5.1) Severe persistent drug-induced myelosuppression [see Warnings and Precautions (5.4) Severe hepatic impairment (defined as Child-Pugh Class C or serum bilirubin level greater than 5 mg/dL) [see Warnings and Precautions (5.5) Severe hypersensitivity to ELLENCE, other anthracyclines, or anthracenediones [see Adverse Reactions (6.1) Severe myocardial insufficiency ( 4 Recent myocardial infarction ( 4 Severe persistent drug-induced myelosuppression ( 4 Severe hepatic impairment ( 4 Severe hypersensitivity to ELLENCE, other anthracyclines, or anthracenediones ( 4\"" . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "GBGUgZEZXyxy3omh1cr3zgocpD5dRa4SjR0hHTMC216qt/42JKR3E2VPDKFnMWluW2eRSHG+jfjj9MeJUxKFGuGXvB5UUlvvtaKwJCiBp/J00qGsFiO0ZBU9VNlYBv+7XNwsBFji0Cw/oEq4lSn5q99oSB6wrNyniYvMGB9ILrc=" . . "2021-08-25T13:53:02.725+02:00"^^ . . . . .